Interactions between intracellular free Ca2+ and cyclic AMP in neuroendocrine cells

Cell Calcium

Volumn 51, Issue 3-4, 2012, Pages 260-266

  Antoni, Ferenc A ^a  

^a Division of Preclinical Research   (Hungary)

Author keywords

Adenylyl cyclase; Calcium; CAMP; Neuroendocrine control; Phosphodiesterase

Indexed keywords

ADENYLATE CYCLASE; ADENYLYL CYCLASE 1; ADENYLYL CYCLASE 3; ADENYLYL CYCLASE 5; ADENYLYL CYCLASE 6; ADENYLYL CYCLASE 8; ADENYLYL CYCLASE 9; AKAP150 PROTEIN; AKAP79 PROTEIN; ARGIPRESSIN; CALCIUM; CALCIUM CHANNEL L TYPE; CALMODULIN; CORTICOTROPIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; GLUCOCORTICOID; PHOSPHODIESTERASE I; RYANODINE RECEPTOR; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ACTH SECRETING CELL; ADENOHYPOPHYSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL MEMBRANE; CELL METABOLISM; CORTICOTROPIN RELEASE; HUMAN; HYPOTHALAMUS; INTRACELLULAR SIGNALING; LIPID RAFT; MITOCHONDRION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING;

MAMMALIA;

EID: 84858277140     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2011.12.013     Document Type: Article

References (89)

1. Sunahara R.K., Dessauer C.W., Gilman A.G. Complexity and diversity of mammalian adenylyl cyclases. Annual Review of Biochemistry 1996, 36:461-480.
2. Antoni F.A. Molecular diversity of cyclic AMP signaling. Frontiers in Neuroendocrinology 2000, 21:103-132.
3. Tresguerres M., Levin L.R., Buck J. Intracellular cAMP signaling by soluble adenylyl cyclase. Kidney International 2011, 79:1277-1288.
4. Litvin T.N., Kamenetsky M., Zarifyan A., Buck J., Levin L.R. Kinetic properties of " soluble" adenylyl cyclase. Synergism between calcium and bicarbonate. Journal of Biological Chemistry 2003, 278:15922-15926.
5. Taylor S.S., Yang J., Wu J., Haste N.M., Radzio-Andzelm E., Anand G. PKA: a portrait of protein kinase dynamics. Biochimica et Biophysica Acta 2004, 1697:259-269.
6. Logue J.S., Scott J.D. Organizing signal transduction through A-kinase anchoring proteins (AKAPs). FEBS J 2010, 277:4370-4375.
7. Keravis T., Lugnier C. Cyclic nucleotide phosphodiesterases (PDE) and peptide motifs. Current Pharmaceutical Design 2010, 16:1114-1125.
8. Gloerich M., Bos J.L. Epac: defining a new mechanism for cAMP action. Annual Review of Pharmacology and Toxicology 2010, 50:355-375.
9. Smith F.D., Scott J.D. Anchored cAMP signaling: onward and upward - a short history of compartmentalized cAMP signal transduction. European Journal of Cell Biology 2006, 85:585-592.
10. Calebiro D., Nikolaev V.O., Persani L., Lohse M.J. Signaling by internalized G-protein-coupled receptors. Trends in Pharmacological Sciences 2010, 31:221-228.
11. Zaccolo M. cAMP signal transduction in the heart: understanding spatial control for the development of novel therapeutic strategies. British Journal of Pharmacology 2009, 158:50-60.
12. 2+ regulation of adenylyl cyclases in cAMP microdomains. Physiological Reviews 2007, 87:965-1010.
13. Houslay M.D. Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown. Trends in Biochemical Sciences 2010, 35:91-100.
14. Hempel C.M., Vincent P., Adams S.R., Tsien R.Y., Selverston A.I. Spatio-temporal dynamics of cyclic AMP signals in an intact neural circuit. Nature 1996, 384:166-169.
15. Antoni FA. New paradigms in cAMP signalling. Molecular and Cellular Endocrinology, doi:10.1016/j.mce.2011.10.034.
16. Ostrom R.S., Insel P.A. The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. British Journal of Pharmacology 2004, 143:235-245.
17. Antoni F.A., Barnard R.J.O., Shipston M.J., Smith S.M., Simpson J., Paterson J.M. Calcineurin feedback inhibition of agonist-evoked cAMP formation. Journal of Biological Chemistry 1995, 270:28055-28061.
18. Martin C., Jacobi J.S., Nava G., Jeziorski M.C., Clapp C., Martinez de la Escalera G. GABA inhibition of cyclic AMP production in immortalized GnRH neurons is mediated by calcineurin-dependent dephosphorylation of adenylyl cyclase 9. Neuroendocrinology 2007, 85:257-266.
19. Antoni F.A., Sosunov A.A., Haunso A., Paterson J.M., Simpson J. Short-term plasticity of cyclic adenosine 3',5'-monophosphate signaling in anterior pituitary corticotrope cells: the role of adenylyl cyclase isotypes. Molecular Endocrinology 2003, 17:692-703.
20. Kusumi A., Nakada C., Ritchie K., Murase K., Suzuki K., Murakoshi H., Kasai R.S., Kondo J., Fujiwara T. Paradigm shift of the plasma membrane concept from the two-dimensional continuum fluid to the partitioned fluid: high-speed single-molecule tracking of membrane molecules. Annual Review of Biophysics and Biomolecular Structure 2005, 34:351-378.
21. Lingwood D., Simons K. Lipid rafts as a membrane-organizing principle. Science 2010, 327:46-50.
22. Faux M.C., Scott J.D. Molecular glue - kinase anchoring and scaffold proteins. Cell 1996, 85:9-12.
23. 2+-dependent cAMP synthesis in pancreatic and neuronal systems. Journal of Biological Chemistry 2010, 285:20328-20342.
24. McConnachie G., Langeberg L.K., Scott J.D. AKAP signaling complexes: getting to the heart of the matter. Trends in Molecular Medicine 2006, 12:317-323.
25. Glantz S.B., Amat J.A., Rubin C.S. cAMP signaling in neurons: patterns of neuronal expression and intracellular localization for a novel protein, AKAP 150, that anchors the regulatory subunit of cAMP-dependent protein kinase II beta. Molecular Biology of the Cell 1992, 3:1215-1228.
26. Ostroveanu A., Van der Zee E.A., Dolga A.M., Luiten P.G., Eisel U.L., Nijholt I.M. A-kinase anchoring protein 150 in the mouse brain is concentrated in areas involved in learning and memory. Brain Research 2007, 1145:97-107.
27. Chen Q., Weiner R.I., Blackman B.E. Decreased expression of A-kinase anchoring protein 150 in GT1 neurons decreases neuron excitability and frequency of intrinsic gonadotropin-releasing hormone pulses. Endocrinology 2010, 151:281-290.
28. Jasoni C.L., Romano N., Constantin S., Lee K., Herbison A.E. Calcium dynamics in gonadotropin-releasing hormone neurons. Frontiers in Neuroendocrinology 2010, 31:259-269.
29. Kapiloff M.S., Jackson N., Airhart N. mAKAP and the ryanodine receptor are part of a multi-component signaling complex on the cardiomyocyte nuclear envelope. Journal of Cell Science 2001, 114:3167-3176.
30. 2+/calmodulin-dependent protein kinase II and modulate phospholamban phosphorylation. Journal of Biological Chemistry 2009, 284:28212-28221.
31. Zippin J.H., Chen Y., Nahirney P., Kamenetsky M., Wuttke M.S., Fischman D.A., Levin L.R., Buck J. Compartmentalization of bicarbonate-sensitive adenylyl cyclase in distinct signaling microdomains. FASEB Journal 2003, 17:82-84.
32. Ramos L.S., Zippin J.H., Kamenetsky M., Buck J., Levin L.R. Glucose and GLP-1 stimulate cAMP production via distinct adenylyl cyclases in INS-1E insulinoma cells. Journal of General Physiology 2008, 132:329-338.
33. Tian G., Sandler S., Gylfe E., Tengholm A. Glucose- and hormone-induced cAMP oscillations in alpha- and beta-cells within intact pancreatic islets. Diabetes 2011, 60:1535-1543.
34. 2+/calmodulin of type 1 and 8 adenylyl cyclases support their different physiological roles. Journal of Biological Chemistry 2009, 284:4451-4463.
35. 2+ channel activity in area CA1 of hippocampus. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:6467-6471.
36. Chetkovich D.M., Sweatt J.D. NMDA receptor activation increases cyclic AMP in area CA1 of the hippocampus via calcium/calmodulin stimulation of adenylyl cyclase. Journal of Neurochemistry 1993, 61:1933-1942.
37. 2+/calmodulin-stimulated activity in the hypothalamus. Journal of Neuroendocrinology 1994, 6:665-671.
38. 2+-sensitive adenylyl cyclase in gonadotropin-releasing hormone neurons. Molecular Endocrinology 2001, 15:429-440.
39. Wayman G.A., Wei J., Wong S., Storm D.R. Regulation of type I adenylyl cyclase by calmodulin kinase IV in vivo. Molecular and Cellular Biology 1996, 16:6075-6082.
40. Ferguson G.D., Storm D.R. Why calcium-stimulated adenylyl cyclases?. Physiology (Bethesda) 2004, 19:271-276.
41. Xia Z., Choi E.J., Wang F., Storm D.R. The type III calcium/calmodulin-sensitive adenylyl cyclase is not specific to olfactory sensory neurons. Neuroscience Letters 1992, 144:169-173.
42. Chaudhry A., Muffler L.A., Yao R., Granneman J.G. Perinatal expression of adenylyl cyclase subtypes in rat brown adipose tissue. American Journal of Physiology 1996, 270:R755-R760.
43. Bishop G.A., Berbari N.F., Lewis J., Mykytyn K. Type III adenylyl cyclase localizes to primary cilia throughout the adult mouse brain. Journal of Comparative Neurology 2007, 505:562-571.
44. Wang Z., Li V., Chan G.C.K., Phan T., Nudelman A.S., Xia Z., Storm D.R. Adult type 3 adenylyl cyclase-deficient mice are obese. PLoS ONE 2009, 4:e6979.
45. Wang Z., Phan T., Storm D.R. The type 3 adenylyl cyclase is required for novel object learning and extinction of contextual memory: role of cAMP signaling in primary cilia. Journal of Neuroscience 2011, 31:5557-5561.
46. Choi E.J., Xia Z., Storm D.R. Stimulation of the type III olfactory adenylyl cyclase by calcium and calmodulin. Biochemistry 1992, 31:6492-6498.
47. Wei J., Zhao A.Z., Chan G.C., Baker L.P., Impey S., Beavo J.A., Storm D.R. Phosphorylation and inhibition of olfactory adenylyl cyclase by CaM kinase II in neurons: a mechanism for attenuation of olfactory signals. Neuron 1998, 21:495-504.
48. Hanoune J., Defer N. Regulation and role of adenylyl cyclase isoforms. Annual Review of Pharmacology and Toxicology 2001, 41:145-174.
49. Paterson J.M., Smith S.M., Harmar A.J., Antoni F.A. Control of a novel adenylyl cyclase by calcineurin. Biochemical Biophysical Research Communications 1995, 214:1000-1008.
50. Antaraki A., Ang K.L., Antoni F.A. Involvement of calyculin A inhibitable protein phosphatases in the cyclic AMP signal transduction pathway of mouse corticotroph tumour (AtT20) cells. British Journal of Pharmacology 1997, 121:991-999.
51. Conti M., Beavo J. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annual Review of Biochemistry 2007, 76:481-511.
52. Ang K.L., Antoni F.A. Functional plasticity of cyclic AMP hydrolysis in rat adenohypohpysial corticotroph cells. Cellular Signalling 2002, 14:445-452.
53. Ang K.L., Antoni F.A. Reciprocal regulation of calcium dependent and calcium independent cyclic AMP hydrolysis by protein phosphorylation. Journal of Neurochemistry 2002, 81:422-433.
54. Moran M.M., McAlexander M.A., Biro T., Szallasi A. Transient receptor potential channels as therapeutic targets. Nature Reviews Drug Discovery 2011, 10:601-620.
55. Shen B., Kwan H.Y., Ma X., Wong C.O., Du J., Huang Y., Yao X. cAMP activates TRPC6 channels via the phosphatidylinositol 3-kinase (PI3K)-protein kinase B (PKB)-mitogen-activated protein kinase kinase (MEK)-ERK1/2 signaling pathway. Journal of Biological Chemistry 2011, 286:19439-19445.
56. Soulsby M.D., Wojcikiewicz R.J. The type III inositol 1,4,5-trisphosphate receptor is phosphorylated by cAMP-dependent protein kinase at three sites. Biochemical Journal 2005, 392:493-497.
57. Tovey S.C., Dedos S.G., Rahman T., Taylor E.J., Pantazaka E., Taylor C.W. Regulation of inositol 1,4,5-trisphosphate receptors by cAMP independent of cAMP-dependent protein kinase. Journal of Biological Chemistry 2010, 285:12979-12989.
58. 2+ release activity of the inositol 1,4,5-trisphosphate receptor type 3 in RINm5F cells. Biologie Cellulaire 2007, 99:379-388.
59. Hamilton S.L., Serysheva I.I. Ryanodine receptor structure: progress and challenges. Journal of Biological Chemistry 2009, 284:4047-4051.
60. Wehrens X.H., Marks A.R. Altered function and regulation of cardiac ryanodine receptors in cardiac disease. Trends in Biochemical Sciences 2003, 28:671-678.
61. 2+ release and exocytosis in pancreatic beta-cells. Journal of Biological Chemistry 2003, 278:8279-8285.
62. Antoni F.A. Vasopressinergic control of anterior pituitary adrenocorticotropin secretion comes of age. Frontiers in Neuroendocrinology 1993, 14:76-122.
63. Dallman M.F., Akana S.F., Scribner K., Bradbury M.J., Walker C.-D., Strack A.M., Cascio C.S. Stress, feedback and facilitation on the hypothalamo-pituitary-adrenal axis. Journal of Neuroendocrinology 1992, 4:517-526.
64. Phillips M.A, Tashjian A.H. Characterisation of an early inhibitory effect of glucocorticoids on stimulated adrenocorticotropin and endorphin release from a clonal strain of mouse pituitary cells. Endocrinology 1982, 110:892-900.
65. Woods M.D., Hoyland J., Mason W., Antoni F.A. Rapid inhibition of stimulus evoked hormone release and intracellular calcium transients by mifepristone (RU 38486) and pregnane derivatives in mouse pituitary corticotroph tumour cells. BNG Physiological Societies Symposium, BPC 30 1991.
66. Dayanithi G., Antoni F.A. Rapid as well as delayed inhibitory effects of glucocorticoid hormones on pituitary adrenocorticotropic hormone release are mediated by Type II glucocorticoid receptors and require newly synthesized messenger ribonucleic acid as well as protein. Endocrinology 1989, 125:308-313.
67. Shipston M.J., Antoni F.A. Early glucocorticoid feedback in anterior pituitary corticotrophs: differential inhibition of hormone release induced by vasopressin and corticotrophin releasing factor in vitro. Journal of Endocrinology 1991, 129:261-267.
68. Antoni F.A., Hoyland J., Woods M.D., Mason W.T. Glucocorticoid inhibition of stimulus-evoked adrenocorticotrophin release caused by suppression of intracellular calcium signals. Journal of Endocrinology 1992, 133:R13-R16.
69. Ang K-L. Differential Regulation of Cyclic Nucleotide Phosphodiesterases in Anterior Pituitary Cells 1999, Department of Neuroscience. University of Edinburgh, Edinburgh.
70. Shipston M.J., Duncan R.R., Clark A.G., Antoni F.A., Tian L. Molecular components of large conductance calcium activated potassium (BK) channels in mouse pituitary corticotropes. Molecular Endocrinology 1999, 13:1728-1737.
71. Tian L., Duncan R.R., Hammond M.S., Coghill L.S., Wen H., Rusinova R., Clark A.G., Levitan I.B., Shipston M.J. Alternative splicing switches potassium channel sensitivity to protein phosphorylation. Journal of Biological Chemistry 2001, 276:7717-7720.
72. Shipston M.J., Kelly J.S., Antoni F.A. Glucocorticoids block protein kinase A inhibition of calcium-activated potassium channels. Journal of Biological Chemistry 1996, 271:9197-9200.
73. Tian L.J., Knaus H.G., Shipston M.J. Glucocorticoid regulation of calcium-activated potassium channels mediated by serine/threonine protein phosphatase. Journal of Biological Chemistry 1998, 273:13531-13536.
74. Tian L., Hammond M.S., Florance H., Antoni F.A., Shipston M.J. Alternative splicing determines sensitivity of murine calcium-activated potassium channels to glucocorticoids. Journal of Physiology 2001, 537:57-68.
75. Saito M., Nelson C., Salkoff L., Lingle C.J. A cysteine-rich domain defined by a novel exon in a slo variant in rat adrenal chromaffin cells and PC12 cells. Journal of Biological Chemistry 1997, 272:11710-11717.
76. Erxleben C., Everhart A.L., Romeo C., Florance H., Bauer M.B., Alcorta D.A., Rossie S., Shipston M.J., Armstrong D.L. Interacting effects of N-terminal variation and strex exon splicing on slo potassium channel regulation by calcium, phosphorylation, and oxidation. Journal of Biological Chemistry 2002, 277:27045-27052.
77. Cheng H., Lederer W.J. Calcium sparks. Physiological Reviews 2008, 88:1491-1545.
78. Marcantoni A., Vandael D.H., Mahapatra S., Carabelli V., Sinnegger-Brauns M.J., Striessnig J., Carbone E. Loss of Cav1.3 channels reveals the critical role of L-type and BK channel coupling in pacemaking mouse adrenal chromaffin cells. Journal of Neuroscience 2010, 30:491-504.
79. Shipston M.J., Hernando F., Barnard R.J.O., Antoni F.A. Glucocorticoid negative feedback in pituitary corticotropes: pivotal role for calcineurin inhibition of adenylyl cyclase. Annals of the New York Academy of Sciences 1994, 746:453-455.
80. Lai G.J., McCobb D.P. Regulation of alternative splicing of Slo K+ channels in adrenal and pituitary during the stress-hyporesponsive period of rat development. Endocrinology 2006, 147:3961-3967.
81. + channels reverses the inhibition of secretagogue stimulated ACTH release by atriopeptin. Journal of Endocrinology 1990, 126:183-191.
82. Lim M.C., Shipston M.J., Antoni F.A. Depolarisation counteracts glucocorticoid inhibition of adenohypophysial corticotroph cells. British Journal of Pharmacology 1998, 124:1735-1743.
83. Lim M.C., Shipston M.J., Antoni F.A. Posttranslational modulation of glucocorticoid feedback inhibition at the pituitary level. Endocrinology 2002, 143:3796-3801.
84. Yamashita M., Oki Y., Iino K., Hayashi C., Matsushita F., Faje A., Nakamura H. The role of ether-a-go-go-related gene K(+) channels in glucocorticoid inhibition of adrenocorticotropin release by rat pituitary cells. Regulatory Peptides 2009, 152:73-78.
85. Plotsky P.M. Pathways to the secretion of adrenocorticotropin: a view from the portal. Journal of Neuroendocrinology 1991, 3:1-9.
86. Chowdrey H.S., Larsen P.J., Harbuz M.S., Jessop D.S., Aguilera G., Eckland D.J., Lightman S.L. Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis. British Journal of Pharmacology 1995, 116:2417-2424.
87. Pronko S.P., Saba L.M., Hoffman P.L., Tabakoff B. Type 7 adenylyl cyclase-mediated hypothalamic-pituitary-adrenal axis responsiveness: influence of ethanol and sex. Journal of Pharmacology and Experimental Therapeutics 2010, 334:44-52.
88. Carvallo P., Aguilera G. Protein kinase C mediates the effect of vasopressin in pituitary corticotrophs. Molecular Endocrinology 1989, 3:1935-1943.
89. Houslay M.D., Baillie G.S., Maurice D.H. cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling. Circulation Research 2007, 100:950-966.